Helius Medical Technologies, Inc. (OTCMKTS:HSDT) Director Dane Andreeff acquired 167,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average cost of $2.58 per share, with a total value of $430,860.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of Helius Medical Technologies, Inc. (HSDT) opened at $2.19 on Tuesday. Helius Medical Technologies, Inc. has a 1-year low of $1.29 and a 1-year high of $4.14.
TRADEMARK VIOLATION NOTICE: “Helius Medical Technologies, Inc. (HSDT) Director Dane Andreeff Acquires 167,000 Shares of Stock” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.chaffeybreeze.com/2017/11/14/helius-medical-technologies-inc-hsdt-director-dane-andreeff-acquires-167000-shares-of-stock.html.
About Helius Medical Technologies
Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.
Receive News & Ratings for Helius Medical Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.